Chapter 10 - CALIFORNIA AFFORDABLE DRUG MANUFACTURING ACT OF 2020
- Section 127690 - Short title
- Section 127691 - Definitions
- Section 127692 - Partnerships to lower prices, address shortages, reduce costs, etc; staffing
- Section 127693 - Partnerships for production or distribution of generic prescription drugs
- Section 127694 - [Effective until 1/1/2028] Feasibility report; repealer
- Section 127694.1 - California-based manufacturing facility for insulin
- Section 127695 - [Effective until 1/1/2028] Status report; repealer
- Section 127696 - Information exempt from disclosure requirements
- Section 127697 - Partnerships regarding over-the-counter naloxone products